Federal Register / Vol. 87, No. 99 / Monday, May 23, 2022 / Notices 31243 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments must be received by 

June 6, 2022. 

ADDRESSES: When commenting, please 

reference the applicable form number 

(see below) and the OMB control 

number (0938–1148). To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: CMS–10398 (#7)/OMB 

control number: 0938–1148, Room C4– 

26–05, 7500 Security Boulevard, 

Baltimore, Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may access CMS’ 

website at https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Following 

is a summary of the use and burden 

associated with the subject information 

collection(s). More detailed information 

can be found in the collection’s 

supporting statement and associated 

materials (see ADDRESSES). 

Generic Information Collections 

1. Title of Information Collection: 

CHIPRA Connecting Kids to Coverage 

Outreach and Enrollment Grants; Type 

of Information Collection Request: 

Revision of a currently approved 

collection; Use: In this April 2022 

iteration of GenIC#7, regarding MACRA 

Cycle Vb. Round III, the Cycle Vb. 

Connecting Kids to Coverage Final 

Report Template for the Round III AI/ 

AN cooperative agreement is being 

removed because the data collection is 

completed. This April 2022 iteration of 

GenIC#7 also sets out to revise the 

currently approved templates for the 

Semi-Annual Report and Final Report 

Templates and the Monthly Progress 

Report Templates. The revision changes 

the template format from a Microsoft 

Excel spreadsheet to an Adobe pdf. This 

revision makes the reporting templates 

user-friendly for the grantees and easier 

to complete than with the Excel 

spreadsheet format. The content of the 

reporting information continues without 

change as collected through the SemiAnnual Report, Final Report and 

Monthly Progress Report Templates of 

this current package. Form Number: 

CMS–10398 (#7) (OMB control number: 

0938–1148); Frequency: Yearly, 

quarterly, once, and occasionally; 

Affected Public: State, Local, or Tribal 

Governments; Number of Respondents: 

47; Total Annual Responses: 1,973; 

Total Annual Hours: 10,102. (For policy 

questions regarding this collection 

contact Joyce Jordan at 410–786–.) 

Dated: May 17, 2022. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2022–10954 Filed 5–20–22; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Community Living 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; The National Adult 

Maltreatment Reporting System; OMB 

#0985–0054 

AGENCY: Administration for Community 

Living, HHS. 

ACTION: Notice. 

SUMMARY: The Administration for 

Community Living (ACL) is announcing 

an opportunity for the public to 

comment on the proposed collection of 

information listed above. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal agencies are required to 

publish a notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

the proposed revision of information 

collection requirements for the National 

Maltreatment Reporting System 

(NAMRS) OMB Control Number 0985– 

0054. 

DATES: Comments on the collection of 

information must be submitted 

electronically by 11:59 p.m. (EST) or 

postmarked by July 22, 2022. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to Stephanie Whittier 

Eliason, Administration for Community 

Living, Washington, DC 20201, at 

Stephanie.WhittierEliason@acl.hhs.gov. 

Submit written comments on the 

collection of information to 

Administration for Community Living, 

Washington, DC 20201, Attention: to 

Stephanie Whittier Eliason. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Whittier Eliason, 

Administration for Community Living, 

Washington, DC 20201, at 202.795.7467 

and Stephanie.WhittierEliason@

acl.hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

PRA, Federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

‘‘Collection of information’’ includes 

agency requests or requirements that 

members of the public submit reports, 

keep records, or provide information to 

a third party. The PRA requires Federal 

agencies to provide a 60-day notice in 

the Federal Register concerning each 

proposed collection of information, 

including each proposed extension of an 

existing collection of information, 

before submitting the collection to OMB 

for approval. To comply with this 

requirement, ACL is publishing a notice 

of the proposed collection of 

information set forth in this document. 

With respect to the following 

collection of information, ACL invites 

comments on our burden estimates or 

any other aspect of this collection of 

information, including: 

(1) Whether the proposed collection 

of information is necessary for the 

proper performance of ACL’s functions, 

including whether the information will 

have practical utility; 

(2) the accuracy of ACL’s estimate of 

the burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used 

to determine burden estimates; 

(3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and 

(4) ways to minimize the burden of 

the collection of information on 

respondents, including through the use 

of automated collection techniques 

when appropriate, and other forms of 

information technology. 

This data collection effort is in 

response to the Elder Justice Act of 

2009, which amended Title XX of the 

Social Security Act [42.U.S.C. 13976 et 

seq.]. These provisions require that the 

Secretary of HHS ‘‘collects and 

disseminates data annually relating to 

the abuse, exploitation, and neglect of 

elders in coordination with the 

Department of Justice’’ [Sec. 


lotter on DSK11XQN23PROD with NOTICES1
31244 Federal Register / Vol. 87, No. 99 / Monday, May 23, 2022 / Notices 

2041(a)(1)(B)], and ‘‘conducts research 

related to the provision of adult 

protective services’’ [Sec. 2041(a)(1)(D)]. 

Furthermore, development of a national 

adult protective services (APS) system 

based upon standardized data collection 

and a core set of service provision 

standards and best practices was 

recommended by the Elder Justice 

Coordinating Council to increase federal 

involvement in addressing elder abuse, 

neglect and exploitation. Since federal 

fiscal year 2016, NAMRS has collected 

descriptive and summary or deidentified case-level data on APS 

investigations. The purpose of NAMRS 

is to better understand adult 

maltreatment as investigated by APS 

programs. Respondents are state APS 

agencies and APS agencies in the 

District of Columbia, Puerto Rico, 

Guam, Northern Mariana Islands, Virgin 

Islands, and American Samoa (states, 

hereafter). Two agencies provide No 

personally identifiable client or 

perpetrator information is collected. 

Data submission is voluntary. 

NAMRS consists of three components: 

(1) Agency Component: Descriptive 

data on APS program agency 

information and key program policies; 

and 

(2) Case Component: De-identified 

case-level data on key aspects of APS 

investigations (e.g., clients, 

maltreatment types, perpetrators); or 

(3) Key Indicator: Summary level data 

on a smaller set of core items about APS 

investigations States unable to submit a 

case-level file through the Case 

Component submit. 

ACL provides technical assistance to 

states to assist in the preparation of their 

data submissions and reviews and 

approves submissions. NAMRS was 

granted a three-year extension through 

March of 2023. To prepare for the 2023 

OMB reauthorization, ACL routinely 

collects potential changes to NAMRS 

and held 11 public listening sessions 

during the summer of 2021 to obtain 

feedback from stakeholders on potential 

improvements to NAMRS. 

ACL then conducted four focus 

groups with state APS agencies to 

discuss potential changes to NAMRS 

identified in the 11 listening sessions. 

With input of the technical assistance 

team, ACL determined the proposed 

revisions to the information collection. 

In summary, the proposed revisions 

clarify definitions and instructions 

throughout, add new policy questions to 

the Agency Component to assist data 

users with interpreting data, add new 

code values to various Case Component 

and Key Indicator data elements in 

response to stakeholder input, and add 

one new data element to the Case 

Component. The annual recurring 

burden for states will increase slightly, 

and there will be one-time burden to 

make changes in APS program 

information systems. ACL intends to 

make state-specific NAMRS data 

available to researchers and other 

potential users through a request and 

approval process. The process will 

include safeguards for APS program 

confidentiality concerns. 

The proposed data collection tools 

may be reviewed on the ACL website at 

https://www.acl.gov/about-acl/publicinput. 

Estimated Program Burden 

The proposed revisions add only one 

new data element, make minor 

additions to the code values for a 

number of Key Indicator and Case 

Component data elements, and include 

a number of new policy questions in the 

Agency Component. For the new data 

element and additional code values, 

state APS programs may choose to 

modify their information management 

systems to collect the data and extract 

it for reporting. This will be a one-time 

burden. In addition, states will have an 

ongoing annual burden of preparing and 

submitting the data collection. 

Since initial establishment of the data 

collection, NAMRS reporting has 

become more efficient through state 

familiarity with the system and 

improvements such as a ‘‘copy forward’’ 

feature for Case Mapping and Agency 

Component items. For the new policy 

questions in the revision, ACL assumes 

it will pre-load responses for many of 

the questions for many of the states, 

requiring only state validation of the 

accuracy of the information and a very 

minimal increase in ongoing burden. 

Based on current submission and 

anticipated changes, ACL estimates 59 

APS programs will respond every year 

to the Agency Component, with 50 

states providing Case Component data 

and 9 states providing Key Indicator 

data. (Note: In three states, 

Based on the previous estimates of 

annual submission burden from data 

gathered during the pilot project, the 

recurring annual burden to submit the 

data consists of: 

• Hours by administrative staff to 

respond to the Agency Component, and 

• Hours by data staff and 

administrative staff to respond to the 

Key Indicator Component, or 

• Hours by data staff and 

administrative to respond and jointly 

complete the Case Component. 

The one-time burden for the revisions 

will take: 

• Hours for administrative to review 

or add additional information for the 

new policy questions. 

• Hours for programming for the new 

Key Indicator and Case Component code 

values. 

• Hours for programming for the new 

Case Component data element. 

Recurring and one-time burden 

estimates are shown in the following 

table. 

Respondent/data collection activity Number of 

respondents 

Responses 

per 

respondent 

Hours per 

response 

Annual burden 

estimate 

Agency One-Time ............................................................................................ 59 1 6.20 365.80 

Key Indicator One-Time ................................................................................... 9 1 30.00 270.00 

Case Component One-Time ............................................................................ 50 1 83 4,150.00 

One-Time Subtotal ................................................................................... ........................ ........................ 119.20 4,785.80 

Agency Component ......................................................................................... 59 1 4 236.00 

Key Indicators Component .............................................................................. 9 1 20 180.00 

Case Component ............................................................................................. 50 1 100 5,000.00 

Recurring Sub-total ................................................................................... ........................ ........................ 124 5,416.00 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 99 / Monday, May 23, 2022 / Notices 31245 

Dated: May 17, 2022. 

Alison Barkoff, 

Acting Administrator and Assistant Secretary 

for Aging. 

[FR Doc. 2022–10987 Filed 5–20–22; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2022–N–0619] 

Advisory Committee; Gastrointestinal 

Drugs Advisory Committee; Renewal; 

Correction 

AGENCY: Food and Drug Administration, 

HHS 

ACTION: Notice; correction. 

SUMMARY: The Food and Drug 

Administration (FDA) is correcting a 

notice entitled ‘‘Advisory Committee; 

Gastrointestinal Drugs Advisory 

Committee; Renewal’’ that appeared in 

the Federal Register of May 11, 2022. 

The document announced the renewal 

of the Gastrointestinal Drugs Advisory 

Committee. The document was 

published with the incorrect docket 

number. This document corrects that 

error. 

FOR FURTHER INFORMATION CONTACT: 

Rhea Bhatt, Division of Advisory 

Committee and Consultant 

Management, Center for Drug 

Evaluation and Research, Food and 

Drug Administration, 10903 New 

Hampshire Ave., Bldg. 31, Rm. 2434, 

Silver Spring, MD 20993–0002, 301– 

796–9001, email: GIDAC@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of Wednesday, May 11, 

2022 (87 FR 28834), in FR Doc. 2022– 

10040, on page 28834, the following 

correction is made: 

1. On page 28834, in the first column 

of the header of the document, ‘‘Docket 

No. FDA–2021–N–0619’’ is corrected to 

read ‘‘Docket No. FDA–2022–N–0619’’. 

Dated: May 13, 2022. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2022–10941 Filed 5–20–22; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Presidential Advisory 

Council on Combating AntibioticResistant Bacteria 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that a meeting is scheduled to be held 

for the Presidential Advisory Council on 

Combating Antibiotic-Resistant Bacteria 

(PACCARB). The meeting will be open 

to the public; a pre-registered public 

comment session will be held during 

the meeting. Pre-registration is required 

for members of the public who wish to 

attend the meeting and who wish to 

participate in the public comment 

session. Individuals who wish to attend 

the meeting and/or send in their public 

comment via email should send an 

email to CARB@hhs.gov. Registration 

information is available on the website 

http://www.hhs.gov/paccarb and must 

be completed by September 5, 2022; all 

in-person attendees must pre-register by 

this date and will be given priority over 

unregistered attendees. Additional 

information about any updates to 

COVID–19 safety precautions or 

requirements, including how to register 

for the meeting and provide public 

comment, can be obtained at http://

www.hhs.gov/paccarb on the Meetings 

page. Please visit the page for frequent 

updates. 

DATES: The meeting is tentatively 

scheduled to be held on September 12, 

from 9:00 a.m. to 5:00 p.m., and 

September 13, 2022, from 9:00 a.m. to 

5:00 p.m. ET (all times are subject to 

change). The confirmed times and 

agenda items for the meeting will be 

posted on the website for the PACCARB 

at http://www.hhs.gov/paccarb when 

this information becomes available. Preregistration for attending the meeting in 

person is required to be completed no 

later than September 5, 2022; public 

attendance at the meeting is limited to 

the available space. 

ADDRESSES: Tysons Corner Marriott, 

8028 Leesburg Pike, Tysons Corner, 

Virginia 22182. The meeting can also be 

accessed through a live webcast and via 

teleconference on the day of the 

meeting. For more information, visit 

http://www.hhs.gov/paccarb. 

FOR FURTHER INFORMATION CONTACT: 

Jomana Musmar, M.S., Ph.D., 

Designated Federal Officer, Presidential 

Advisory Council on Combating 

Antibiotic-Resistant Bacteria, Office of 

the Assistant Secretary for Health, U.S. 

Department of Health and Human 

Services, Room L616, Switzer Building, 

330 C St. SW, Washington, DC 20201. 

Email: CARB@hhs.gov. Telephone: (202) 

746–1512. 

SUPPLEMENTARY INFORMATION: The 

Presidential Advisory Council on 

Combating Antibiotic-Resistant Bacteria 

(PACCARB), established by Executive 

Order 13676, is continued by Section 

505 of Public Law 116–22, the 

Pandemic and All-Hazards 

Preparedness and Advancing Innovation 

Act of 2019 (PAHPAIA). Activities and 

duties of the Advisory Council are 

governed by the provisions of the 

Federal Advisory Committee Act 

(FACA), Public Law 92–463, as 

amended (5 U.S.C. App.), which sets 

forth standards for the formation and 

use of federal advisory committees. 

The PACCARB shall advise and 

provide information and 

recommendations to the Secretary 

regarding programs and policies 

intended to reduce or combat antibioticresistant bacteria that may present a 

public health threat and improve 

capabilities to prevent, diagnose, 

mitigate, or treat such resistance. The 

PACCARB shall function solely for 

advisory purposes. 

Such advice, information, and 

recommendations may be related to 

improving: The effectiveness of 

antibiotics; research and advanced 

research on, and the development of, 

improved and innovative methods for 

combating or reducing antibiotic 

resistance, including new treatments, 

rapid point-of-care diagnostics, 

alternatives to antibiotics, including 

alternatives to animal antibiotics, and 

antimicrobial stewardship activities; 

surveillance of antibiotic-resistant 

bacterial infections, including publicly 

available and up-to-date information on 

resistance to antibiotics; education for 

health care providers and the public 

with respect to up-to-date information 

on antibiotic resistance and ways to 

reduce or combat such resistance to 

antibiotics related to humans and 

animals; methods to prevent or reduce 

the transmission of antibiotic-resistant 

bacterial infections; including 

stewardship programs; and coordination 

with respect to international efforts in 

order to inform and advance the United 

States capabilities to combat antibiotic 

resistance. 

The September 12–13, 2022 public 

meeting will be dedicated to a One 

Health AMR and Pandemic 

Preparedness Policy Workshop with the 

goal of identifying key issues and 

critical policy gaps through a series of 

facilitated discussions examining a 

hypothetical large-scale disease 

outbreak scenario based on historic 

examples and estimates of future AMR 


lotter on DSK11XQN23PROD with NOTICES1